Dec 17, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Oct 2, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

Aug 7, 2024 06:50AM Arcturus Therapeutics (ARCT) PT Raised to $63 at H.C. Wainwright

Jul 2, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)

May 11, 2023 06:21AM H.C. Wainwright Upgrades Arcturus Therapeutics (ARCT) to Buy, 'Expecting ARCT-154 Approval in Japan As COVID-19 Vaccine and Booster in 2023'

Mar 1, 2022 11:56AM UPDATE: Arcturus Therapeutics (ARCT) PT Lowered to $25 at H.C. Wainwright

Feb 18, 2022 06:17AM Arcturus Therapeutics (ARCT) Maintained at Neutral by H.C. Wainwright, Waiting for Pivotal Data for Arcturus' COVID-19 Vaccine Approval

Jan 26, 2022 07:42AM Arcturus Therapeutics (ARCT) PT Lowered to $33 at H.C. Wainwright

Dec 29, 2020 08:14AM Arcturus (ARCT) Crashes 37% After 'Underwhelming' COVID-19 Vaccine Data Update, At Least 4 Firms Downgrade

Nov 10, 2020 12:39PM Arcturus Therapeutics (ARCT) PT Raised to $84 at H.C. Wainwright, Following Earnings

Apr 5, 2019 07:09AM H.C. Wainwright Starts Arcturus Therapeutics (ARCT) at Buy